379 related articles for article (PubMed ID: 19945632)
21. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
Watanabe M; Natsuga K; Shinkuma S; Shimizu H
J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
[TBL] [Abstract][Full Text] [Related]
22. Intracellular expression of type VII collagen in squamous cell carcinoma complicating dystrophic epidermolysis bullosa.
Kanitakis J; Barthélémy H; Faure M; Claudy A
Br J Dermatol; 1997 Aug; 137(2):310-3. PubMed ID: 9292093
[No Abstract] [Full Text] [Related]
23. Denuded congenital lesions: recessive dystrophic epidermolysis bullosa.
Fleming KF; Wu JJ; Dyson SW; Dadras SS; Metz BJ
Dermatol Online J; 2009 Apr; 15(4):4. PubMed ID: 19450397
[TBL] [Abstract][Full Text] [Related]
24. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
Ortiz-Urda S; Garcia J; Green CL; Chen L; Lin Q; Veitch DP; Sakai LY; Lee H; Marinkovich MP; Khavari PA
Science; 2005 Mar; 307(5716):1773-6. PubMed ID: 15774758
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for recessive dystrophic epidermolysis bullosa.
Titeux M; Pendaries V; Hovnanian A
Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
[TBL] [Abstract][Full Text] [Related]
26. [Squamous cell carcinoma complicating an hereditary epidermolysis bullosa].
Mseddi M; Turki H; Marrekchi S; Abdelmaksoud W; Masmoudi A; Bouassida S; Zahaf A
Cancer Radiother; 2004 Aug; 8(4):266-9. PubMed ID: 15450521
[TBL] [Abstract][Full Text] [Related]
27. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
Jacków J; Rami A; Hayashi R; Hansen C; Guo Z; DeLorenzo D; Pappalardo A; Alvarez Cespedes D; Kim AL; Perez-Lorenzo R; Owens DM; Christiano AM
J Invest Dermatol; 2021 Apr; 141(4):942-946. PubMed ID: 33069729
[No Abstract] [Full Text] [Related]
28. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
[TBL] [Abstract][Full Text] [Related]
30. Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness.
Weinel S; Lucky AW; Uitto J; Pfendner EG; Choo D
Pediatr Dermatol; 2008; 25(2):210-4. PubMed ID: 18429782
[TBL] [Abstract][Full Text] [Related]
31. [Localised de novo dominant dystrophic epidermolysis bullosa].
Bursztejn AC; Pinault AL; Le Louarn Y; Lacour JP; Charlesworth A; Meneguzzi G; Truchetet F
Ann Dermatol Venereol; 2008 Mar; 135(3):195-9. PubMed ID: 18374850
[TBL] [Abstract][Full Text] [Related]
32. A case of recessive dystrophic epidermolysis bullosa caused by compound heterozygous mutations in the COL7A1 gene.
Suzuki S; Shimomura Y; Yamamoto Y; Kariya N; Shibuya M; Ito M; Fujiwara H
Br J Dermatol; 2006 Oct; 155(4):838-40. PubMed ID: 16965439
[No Abstract] [Full Text] [Related]
33. A rare case of recessive dystrophic epidermolysis bullosa and verruciform xanthoma.
Orpin SD; Scott IC; Rajaratnam R; Colloby PS; Heagerty A
Clin Exp Dermatol; 2009 Jan; 34(1):49-51. PubMed ID: 18681870
[TBL] [Abstract][Full Text] [Related]
34. A novel indel COL7A1 mutation 8068del17insGA causes dominant dystrophic epidermolysis bullosa.
Sawamura D; Nizeki H; Miyagawa S; Shinkuma S; Shimizu H
Br J Dermatol; 2006 May; 154(5):995-7. PubMed ID: 16634910
[No Abstract] [Full Text] [Related]
35. Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations.
Schumann H; Has C; Kohlhase J; Bruckner-Tuderman L
Br J Dermatol; 2008 Aug; 159(2):464-9. PubMed ID: 18565177
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin.
Fine JD; Johnson LB; Weiner M; Stein A; Suchindran C
J Am Acad Dermatol; 2004 Apr; 50(4):563-71. PubMed ID: 15034505
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
Dang N; Murrell DF
Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
[TBL] [Abstract][Full Text] [Related]
38. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.
Slater SD; McGrath JA; Hobbs C; Eady RA; McKee PH
Histopathology; 1992 Mar; 20(3):237-41. PubMed ID: 1563710
[TBL] [Abstract][Full Text] [Related]
39. Mohs micrographic surgery for squamous cell carcinoma associated with epidermolysis bullosa.
Saxena A; Lee JB; Humphreys TR
Dermatol Surg; 2006 Jan; 32(1):128-34. PubMed ID: 16393614
[No Abstract] [Full Text] [Related]
40. [Role of cutaneous pinch grafts in the healing of patients with dystrophic epidermolysis bullosa wounds: report of four cases].
Claude O; Binder JP; Bustamante K; Blanchet-Bardon C; Andrivon F; Revol M; Servant JM
Ann Chir Plast Esthet; 2005 Jun; 50(3):189-96. PubMed ID: 15963838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
